XML 41 R29.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Business Segment Information (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2018
Segment Reporting [Abstract] |
Information concerning unaudited consolidated operations by business segment | Information concerning unaudited consolidated operations by business segment is presented in the following table (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2018 |  | 2017 |  | 2018 |  | 2017
Net Sales |  |  |  |  |  |  |
Medical Devices | $ | 160.9 |  |  | $ | 149.1 |  |  | $ | 317.3 |  |  | $ | 294.8 |
Corporate and Other | — |  |  | — |  |  | — |  |  | — |
Total Net Sales | 160.9 |  |  | 149.1 |  |  | 317.3 |  |  | 294.8 |
Operating Profit |  |  |  |  |  |  |
Medical Devices | 31.1 |  |  | 40.7 |  |  | 71.2 |  |  | 78.7 |
Corporate and Other(a) | (27.0 | ) |  | (46.5 | ) |  | (72.3 | ) |  | (95.1 | )
Other income (expense), net(b) | 4.7 |  |  | (6.3 | ) |  | 2.9 |  |  | (13.3 | )
Total Operating Profit | 8.8 |  |  | (12.1 | ) |  | 1.8 |  |  | (29.7 | )
Interest income | 2.2 |  |  | 0.5 |  |  | 3.2 |  |  | 0.9 |
Interest expense | (9.9 | ) |  | (7.8 | ) |  | (18.7 | ) |  | (15.4 | )
Income before Income Taxes | $ | 1.1 |  |  | $ | (19.4 | ) |  | $ | (13.7 | ) |  | $ | (44.2 | )
______________________________
(a) | Corporate and Other for the three and six months ended June 30, 2018 includes $9.1 million and $37.0 million, respectively, of costs formerly included in the S&IP business, $14.0 million and $28.5 million, respectively, of general expenses and $3.9 million and $6.8 million, respectively, of restructuring costs (see Note 3, “Restructuring Activities”). Corporate and Other for the three and six months ended June 30, 2017 includes $28.4 million and $57.3 million, respectively, of costs formerly included in the S&IP business, $16.4 million and $34.0 million, respectively, of general expenses, $1.7 million and $3.3 million, respectively, of acquisition-related expenses and zero and $0.5 million for post spin-related items.
(b) | Other expense includes amounts incurred related to litigation matters. See Note 11, “Commitments and Contingencies.”
Net sales by product category | Our management evaluates the product category sales within our reportable business segment. Net sales by product category is presented in the following table (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2018 |  | 2017 |  | 2018 |  | 2017
Net Sales |  |  |  |  |  |  |
Chronic care | $ | 97.1 |  |  | $ | 88.7 |  |  | $ | 194.2 |  |  | $ | 177.3 |
Pain management | 63.8 |  |  | 60.4 |  |  | 123.1 |  |  | 117.5 |
Total net sales | $ | 160.9 |  |  | $ | 149.1 |  |  | $ | 317.3 |  |  | $ | 294.8 |

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration